Chapter 4. Anxiolytic Drugs

  1. Jeffrey A. Lieberman M.D. Professor Chair1 and
  2. Allan Tasman M.D. Professor Chair2

Published Online: 3 JUL 2006

DOI: 10.1002/0470029439.ch4

Handbook of Psychiatric Drugs

Handbook of Psychiatric Drugs

How to Cite

Lieberman, J. A. and Tasman, A. (2006) Anxiolytic Drugs, in Handbook of Psychiatric Drugs, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470029439.ch4

Author Information

  1. 1

    Department of Psychiatry, Columbia University, College of Physicians and Surgeons, and Director, New York State Psychiatric Institute, New York, USA

  2. 2

    Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA

Publication History

  1. Published Online: 3 JUL 2006
  2. Published Print: 31 MAR 2006

ISBN Information

Print ISBN: 9780470028216

Online ISBN: 9780470029435



  • tricyclic antidepressant (TCA) imipramine in panic disorder;
  • antidepressants with anxiolytic properties (SSRIs);
  • buspirone with anxiolytic effect;
  • beta-blocker medications;
  • SSRIs and anxiety disorders;
  • SSRIs in social anxiety disorder (SAD);
  • tricyclic antidepressants in SAD, PD, PTSD and OCD;
  • MAO inhibitor medications;
  • augmentation/adjuvant treatments;
  • sound clinical skill and judgement


This chapter contains sections titled:

  • Introduction

  • A General Approach to Using Medication with Anxious Patients

  • Pharmacology

  • Indications for Use

  • Drug Selection, Dose, and Initiation of Treatment

  • Side Effects

  • Drug Interactions

  • Contraindications and Special Precautions

  • Summary

  • Additional Reading